ESIRI ESIN: Open Payments
NPI 1013147990 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,008 in 136 payments from 13 companies in 2025. Trend: 2023 $3,480 · 2024 $3,290 · 2025 $3,008
Food & beverage: $3,004Education: $4
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $711 |
| Alkermes, Inc. | 21 | $599 |
| E.R. Squibb & Sons, L.L.C. | 24 | $383 |
| Otsuka America Pharmaceutical, Inc. | 19 | $375 |
| Axsome Therapeutics, Inc. | 10 | $191 |
| ABBVIE INC. | 11 | $180 |
| Teva Pharmaceuticals USA, Inc. | 13 | $173 |
| Janssen Pharmaceuticals, Inc | 8 | $158 |
| Vanda Pharmaceuticals Inc. | 5 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
Products named: INGREZZA, ARISTADA, COBENFY, REXULTI, Auvelity, VRAYLAR, INVEGA SUSTENNA, FANAPT.
Industry payments across TN — which companies pay providers there.
